Tinnitus and Cochlear Implants
Launched by UNIVERSITY OF NOTTINGHAM · Oct 12, 2023
Trial Information
Current as of November 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This UK study looks at tinnitus (ringing in the ears) in adults who have severe to profound hearing loss and are getting a cochlear implant in one ear. It’s an observational study, meaning participants will receive standard care and no extra treatments beyond the usual cochlear implant process. Researchers want to know if tinnitus changes after implantation, how common it is before implantation, and how tinnitus relates to hearing improvements, mood, sleep, and overall quality of life after implantation.
Eligible participants are adults 18 or older who are about to receive a unilateral cochlear implant through the NHS in the UK, have not had a cochlear implant before, and can consent and complete online surveys in English. About 50 people are planned to join. Participants will complete online questionnaires before surgery and then at 2 weeks after implant, right after activation, and at 1, 3, and 6 months after activation. The questions cover tinnitus, mood (depression and anxiety), sleep, and overall quality of life, and the process fits in with routine care visits.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older.
- • Determined to be eligible for unilateral cochlear implantation.
- • Did not previously receive a cochlear implant in either ear.
- • Sufficient written or spoken English to participate in study activities.
- • Have access to internet or suitable device to complete online study questionnaires.
- • Able to give informed consent.
- Exclusion Criteria:
- • Significant difficulties preventing independent completion of study activities.
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, Nottinghamshire, United Kingdom
Patients applied
Trial Officials
Derek J Hoare, PhD
Principal Investigator
University of Nottingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported